Nurse Practitioner, Adult Health · Hackensack, NJ
NPI
1659793875
Since 2014
Specialty
Nurse Practitioner, Adult Health
Code 363LA2200X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
92 Second St
Hackensack, NJ, 07601
Phone (551) 996-5900
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.2M
1,631 prescriptions
Company payments, 2025
$445
From 10 companies
Medicare prescription drug claims, 2024
In 2024, the drug Michele Boonstra prescribed most often to Medicare patients was Sulfamethoxazole-Trimethoprim (Sulfamethoxazole/Trimethoprim), with 186 prescriptions and refills. In total Michele Boonstra wrote 1,631 Medicare prescriptions that cost $2.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2014-01-07.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 186 | 243 | 36 | $794 |
| Valacyclovir Valacyclovir Hcl | 145 | 221 | 35 | $6,703 |
| Prednisone Generic | 67 | 85 | 18 | $319 |
| Fluconazole Generic | 61 | 91 | 13 | $3,273 |
| Rezurock Belumosudil Mesylate | 54 | 58 | Under 11 | $1.7M |
| Olanzapine Generic | 45 | 59 | 12 | $449 |
| Azithromycin Generic | 41 | 51 | 18 | $501 |
| Methylprednisolone Generic | 36 | 39 | 23 | $439 |
| Pantoprazole Sodium Generic | 33 | 55 | Under 11 | $166 |
| Posaconazole Generic | 31 | 31 | Under 11 | $45K |
| Gabapentin Generic | 31 | 51 | Under 11 | $280 |
| Acyclovir Generic | 29 | 47 | Under 11 | $703 |
| Escitalopram Oxalate Generic | 29 | 43 | Under 11 | $68.02 |
| Tacrolimus Generic | 28 | 35 | Under 11 | $683 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 27 | 27 | 16 | $595 |
Brand drugs: - claims; generic drugs: 1,416 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michele Boonstra $445 ($445 in general payments such as food, travel and fees) from 10 companies. The largest payer was Daiichi Sankyo Inc. with $156.
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. 4568.T | 3 | $156 |
| Astellas Pharma US Inc 4503.T | 4 | $77.1 |
| Celgene Corporation BMY | 3 | $54.81 |
| Janssen Biotech, Inc. JNJ | 3 | $50.66 |
| Merck Sharp & Dohme LLC MRK | 1 | $20.24 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 1 | $19.56 |
| Incyte Corporation INCY | 1 | $18.33 |
| Taiho Oncology, Inc. 4578.T | 1 | $17.27 |
| Sanofi-Aventis U.S. LLC SNY | 1 | $16.64 |
| Syndax Pharmaceuticals, Inc. SNDX | 1 | $13.91 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.